Abstract
The surveillance of influenza viruses in ARVI structure and study of their properties in epidemic season 2019-2020 in Russian Federation are actual for investigations due to tasks of Global Influenza Strategy initiated by WHO in 2019. The data of epidemiological surveillance on influenza- and ARVI-associated morbidity and hospitalization in different age groups of population were analyzed; virological, genetic and statistical methods were used. Preschool children were involved in epidemic the most. Meanwhile, the highest rate of hospitalization was observed in patients of 18-40 years old. Influenza A(H1N1)pdm09 virus dominated in etiology of ARVI in hospitalized patients and pneumonia. The role of respiratory viruses in severe cases of pneumonia and bronchoalveolar syndrome in children was shown. The differences in spectrum of circulating viruses caused ARVI in different regions of Russia were found. Influenza A(H1N1)pdm09 and B/Victoria-like viruses were the main etiological agents that caused of epidemic; its activity among all ARVI was 7.3 and 8.0%, respectively. The differences in antigenic properties of influenza A(H3N2) and B epidemic strains compared to vaccine viruses were found. The populations of epidemic strains were presented by following dominant genetic groups: 6B1.A5/183P for A(H1N1)pdm09, 3С.2а1b+137F for A(H3N2) and V1A.3 line B/Victoria-like for B viruses. The good profile of epidemic strains susceptibility to anti-neuraminidase inhibitors has been saved. The most of the studied influenza strains had the receptor specificity characteristic of human influenza viruses. Obtained results identified the peculiarities of viruses caused the influenza and ARVI in epidemic season 2019-2020 in different regions of Russia. These results suggested the important role of influenza A(H1N1) pdm09 in severe cases and pneumonia in adults 18-40 years old. The continuing drift in influenza viruses was found, which, apparently, could not but affect the efficacy of vaccine prophylaxis and was also considered in the recommendations of WHO experts on the composition of influenza vaccines for the countries of the Northern Hemisphere in the 2020-2021 season.
Highlights
The surveillance of influenza viruses in ARVI structure and study of their properties in epidemic season 2019–2020 in Russian Federation are actual for investigations due to tasks of Global Influenza Strategy initiated by WHO in 2019
Influenza A(H1N1)pdm09 and B/Victoria-like viruses were the main etiological agents that caused of epidemic; its activity among all ARVI was 7.3 and 8.0%, respectively
The populations of epidemic strains were presented by following dominant genetic groups: 6B1.A5/183P for A(H1N1)pdm09, 3С.2а1b+137F for A(H3N2) and V1A.3 line B/Victoria-like for B viruses
Summary
Особенности циркуляции вирусов гриппа и ОРВИ в эпидемическом сезоне 2019–2020 гг. в отдельных регионах России. Особенности циркуляции вирусов гриппа и ОРВИ в эпидемическом сезоне 2019–2020 гг. Львов Д.К.1, Бурцева Е.И.1, Колобухина Л.В.1, Федякина И.Т.1, Бовин Н.В.2, Игнатьева А.В.1, Краснослободцев К.Г.1, Феодоритова Е.Л.1, Трушакова С.В.1, Бреслав Н.В.1, Меркулова Л.Н.1, Мукашева Е.А.1, Хлопова И.Н.1, Воронина О.Л.1, Аксёнова Е.И.1, Кунда М.С.1, Рыжова Н.Н.1, Вартанян H.В.1, Кистенёва Л.Б.1, Кириллов И.М.1, Прошина Е.С.1, Росаткевич А.Г.1, Кружкова И.С.1, Заплатников А.Л.3, Базарова М.В.4, Сметанина С.В.4, Харламов М.В.5, Карпов Н.Л.6, Шихин А.В.7. Для цитирования: Львов Д.К., Бурцева Е.И., Колобухина Л.В., Федякина И.Т., Бовин Н.В., Игнатьева А.В., Краснослободцев К.Г., Феодоритова Е.Л., Трушакова С.В., Бреслав Н.В., Меркулова Л.Н., Мукашева Е.А., Хлопова И.Н., Воронина О.Л., Аксёнова Е.И., Кунда М.С., Рыжова Н.Н., Вартанян H.В., Кистенёва Л.Б., Кириллов И.М., Прошина Е.С., Росаткевич А.Г., Кружкова И.С., Заплатников А.Л., Базарова М.В., Сметанина С.В., Харламов М.В., Карпов Н.Л., Шихин А.В.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
